Beam Therapeutics AUDIT: Beam Therapeutics: The Clinical Dead Zone A forensic audit of Beam Therapeutics (BEAM-302) reveals severe liver toxicity, a 12-month FDA hold, and executive de-risking in the gene surgery space.
